Small

Zacks Small Cap Analysis – TRC: Consider Shareholder Vote has Optimistic Implications for Firm Course, New CEO Search – Go Well being Professional

by

By M. Marin NYSE:TRC READ THE FULL TRC RESEARCH REPORT Firm proposed board members have been authorised, however by dwindling % of shareholders … Tejon Ranch Firm (NYSE:TRC) held its annual assembly of shareholders on Could 14, 2024. The corporate proposed the reelection of eight administrators and the approval of named govt officer compensation, amongst … Read more

Is search engine marketing Value It for a Small Enterprise? – Go Well being Professional

by

Can a Enterprise Survive With out search engine marketing? Technically, a small enterprise might survive with out search engine marketing, however it will more than likely by no means thrive. Many small companies rely on native prospects to remain afloat, and an enormous quantity of native enterprise comes from on-line searches.  In response to statistics … Read more

Zacks Small Cap Analysis – CXW: 1Q24 Beat Highlights Working Leverage, Enhancing Occupancies – Go Well being Professional

by

By M. Marin NYSE:CXW READ THE FULL CXW RESEARCH REPORT Occupancies reached 75.2%, highest degree since pandemic … CoreCivic (NYSE:CXW) reported 1Q24 outcomes that beat our / consensus expectations. Income got here in at $500.7 million in comparison with $458.0 million in 1Q23, up a robust 9.3% y/y. We consider the rise underscores the natural … Read more

Zacks Small Cap Analysis – IMNN: IND Utility Submitted for Part 1/2 Trial of Seasonal COVID-19 Vaccine… – Go Well being Professional

by

By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Enterprise Replace Replace on IMNN-101 Imunon, Inc. (NASDAQ:IMNN) is growing IMNN-101, which is a COVID-19 seasonal vaccine booster primarily based on the corporate’s PlaCCine know-how. It’s a DNA vaccine that addresses quite a lot of limitations of present vaccines, together with the sturdiness of … Read more

Zacks Small Cap Analysis – ENSC Striding Towards Opioid Substitute – Cyber Information

by

By Brad Sorensen, CFA NASDAQ:ENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) launched its 2023 annual report and reiterated the constructive outcomes seen all year long that we now have beforehand reported on. Some highlights: • Money ended the yr at $1.1 million however since, as we’ve famous, the corporate has added $2.1 … Read more